Good morning allFor those with an interest in the B cell...

Good morning all

For those with an interest in the B cell platform, an interesting journal article is now out in the journal "Frontiers In Immunology."

It's a pretty comprehensive overview of current Immunology treatments for Gastric Cancer - those in the market and those under development.

Her-vaxx gets positive coverage on page 11.

https://www.researchgate.net/publication/389847297_HER2-positive_gastric_cancer_from_targeted_therapy_to_CAR-T_cell_therapy

Meanwhile, Prof Kaumaya is presenting on PD1-vaxx and his other B cell vaccines at the World Vaccine Congress on 23 April.

https://www.terrapinn.com/conference/world-vaccine-congress-washington/speaker-pravin-KAUMAYA.stm

As friend @Steini reported back on 28 Feb, the NEO-Polem trial of PD1-vaxx is starting in the UK around now. https://hotcopper.com.au/threads/ann-half-yearly-report-and-accounts.8471016/page-2?post_id=78072188

For more info on that trial: https://www.southampton.ac.uk/ctu/trialportfolio/listoftrials/neopolem.page

Cheers

Dave